Proteins (Proteins, Gene)

Subscribe to Selected New Research on Proteins

58433 relevant articles (864 outcomes, 4906 trials/studies) found for this Bio-Agent

Description: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.

Also Known As:

Proteins, Gene; Gene Proteins; Protein Gene Products; Gene Products, Protein

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Transcription Factors: 10777

Intercellular Signaling Peptides and Proteins: 9177

Carrier Proteins: 7795

Protein Isoforms: 6460

Heat-Shock Proteins: 4611

Membrane Proteins: 4125

Blood Proteins: 3862

Nuclear Proteins: 1357

Aprotinin: 1329

Proteome: 1295

Dietary Proteins: 1248

Lectins: 1248

Viral Proteins: 1170

Tissue Inhibitor of Metalloproteinases: 1010

Nucleoproteins: 1009

Prions: 856

DNA-Binding Proteins: 596

Silk: 585

Apoproteins: 567

Cytoplasmic and Nuclear Receptors: 553

Thioredoxins: 527

Mutant Proteins: 514

Mitochondrial Proteins: 512

Recombinant Proteins: 493

Molecular Chaperones: 466

Cytoskeletal Proteins: 432

Cell Cycle Proteins: 418

Ribosomal Proteins: 410

Globulins: 305

Contractile Proteins: 293

Thymosin: 268

Dynein ATPase: 240

Protein Subunits: 231

Phosphoproteins: 208

histidine-rich proteins: 195

Peptones: 183

Bacterial Proteins: 166

Cerebrospinal Fluid Proteins: 114

Salivary Proteins and Peptides: 90

Cystatins: 80

Pregnancy Proteins: 71

Polyproteins: 63

Protein Hydrolysates: 60

Lithostathine: 59

ATPase inhibitory protein: 58

Iron-Regulatory Proteins: 57

Bio-glue: 51

Egg Proteins: 46

lysosomal proteins: 41

BPC 157: 35

Immediate-Early Proteins: 35

Drug Receptors: 33

Metalloproteins: 33

Plant Proteins: 31

eglin proteinase inhibitors: 29

Iodoproteins: 26

Protein Precursors: 24

Fetal Proteins: 22

leucine-rich repeat proteins: 20

cytoplasmic antiproteinase: 19

Intracellular Signaling Peptides and Proteins: 17

Proteolipids: 16

Seminal Plasma Proteins: 16

cytoplasmic protein A: 15

Fanconi Anemia Complementation Group Proteins: 15

Fungal Proteins: 15

Secretory Proteinase Inhibitory Proteins: 15

ornithine decarboxylase antizyme: 14

protein phosphatase inhibitor-2: 13

Pulmonary Surfactant-Associated Proteins: 13

lucinactant: 12

Avian Proteins: 11

Scleroproteins: 11

Immobilized Proteins: 10

oxygen-regulated proteins: 10

Leydig insulin-like protein: 9

Mesocricetus auratus aphrodisin protein: 8

Ubiquitins: 8

Fish Proteins: 7

frizzled related protein-1: 7

human DNA fragmentation factor: 7

Antifreeze Proteins: 5

BMAP-28: 5

buforin II: 5

fibroblast-derived tumor cytotoxic factor: 5

human monocyte-neutrophil elastase inhibitor: 5

panodin: 5

Experts

1.	Butterfield, D Allan: 20 articles (10/2008 - 05/2002)
2.	Klein, Jon B: 17 articles (05/2008 - 08/2002)
3.	Lubec, G: 13 articles (06/2006 - 01/2001)
4.	Lubec, Gert: 12 articles (05/2008 - 01/2002)
5.	Pierce, William M: 12 articles (04/2008 - 08/2002)
6.	Poon, H Fai: 10 articles (12/2006 - 01/2005)
7.	Zusman, I: 10 articles (08/2001 - 01/2000)
8.	Ben-Hur, H: 10 articles (08/2001 - 01/2000)
9.	Thongboonkerd, Visith: 9 articles (07/2008 - 08/2002)
10.	Safe, Stephen: 9 articles (02/2008 - 02/2004)

Related Diseases

1.	Neoplasms (Cancer) 03/01/2005 - "The ability to identify activated pathways that drive the growth and progression of cancer and to develop specific and potent inhibitors of key proteins in these pathways promises to dramatically change the treatment of cancer: A patient's cancer could be characterized at the molecular level and the information used to select the best treatment options. " 11/01/1996 - "We have shown that the expression of junctional plaque proteins is modulated during growth stimulation and differentiation, and is dramatically reduced in certain tumor cells. " 03/15/2009 - "However, tumor response was improved in those receiving CTL lines with polyclonal vs clonal distribution for subfamilies 2, 3, and 9. Interestingly, in five of six tumors (five Hodgkin's-like and one Burkitt's-like posttransplant lymphoproliferative disease) with restricted viral gene expression a complete response was recorded, although in some cases the tumor cells did not express the proteins recognized by the infused CTL. " 04/30/2007 - "Significant levels of IFN-gamma production by both CD4 and CD8 cells were observed along with CTL responses that were effective against both peptide-pulsed targets as well as syngeneic tumor cells (TC-1) expressing the cognate E6 and E7 proteins. " 09/15/2004 - "Biochemical examination of tumors from GQ-ODN-treated mice demonstrated a significant reduction in Stat3 activation, levels of the antiapoptotic proteins Bcl-2 and Bcl-xL, and an 8-fold increase in the number of apoptotic cells compared with the tumors of placebo-treated mice. " Order ALL the reference details at left...
2.	Infection 02/01/1998 - "Ongoing clinical trials show that ACVs are clearly less reactogenic than WCVs and that ACVs comprised of three to five proteins are highly efficacious in inducing protection against Bordetella pertussis infections. " 06/01/2001 - "The non-structural 3 (NS3) protein is one of the most conserved proteins of hepatitis C virus, and T helper 1 (Th1)-like responses to NS3 in humans correlate with clearance of infection. " 10/01/2006 - "leucopus, separate incorporation of these fusion proteins in an ELISA was very helpful in confirming past or current infections and in identifying specific foci for B. " 10/01/2006 - "However, proteins that afford protection against ROS may play an important role in the survival of the macrophage to LeTx infection as shown by the differences in proteomic responses of the two cell lines to the action of LeTx. " 04/10/1998 - "In contrast, immunization with a combination of p54 and p30 proteins simultaneously stimulated both virus neutralizing mechanisms and modified drastically the disease course, rendering a variable degree of protection ranging from a delay in the onset of the disease to complete protection against virus infection. " Order ALL the reference details at left...
3.	Inflammation 03/01/2004 - "This study was undertaken to test the hypothesis that changes in growth-related proteins are related to decreased inflammation, rather than improvement in nutritional status. " 07/31/2007 - "These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. " 03/02/2004 - "The results support a model in which inflammation is countered through a mechanism that involves complex genetic interactions between Ad early region proteins and offer promise for the design and construction of noninflammatory Ad gene therapy vectors that are relatively easy to grow and purify." 03/01/2004 - "Whether improved growth and increases in growth-related proteins are a consequence of improved nutrition or a reduced inflammation is not known. " 01/01/1975 - "The improved method for staining of cation proteins can be used in determining the fate of cytophagous bacteria, in cytochemistry of cation proteins of polymorphonuclear leucocytes, in detecting vital and perished bacteria in inflammation foci in bacterial infectious processes." Order ALL the reference details at left...
4.	Neurodegenerative Diseases (Neurodegenerative Disease) 01/01/2005 - "Studies of proteins, cells, animal models, and humans suggest that treatments to diminish, or bypass, the reduction in KGDHC might be beneficial in age-related neurodegenerative disorders." 02/01/2009 - "In the light of these changes, these mice may help to understand the molecular processes responsible for these diseases, and they may aid the development of new therapeutic strategies to treat neurodegenerative diseases related to tau and parkin proteins." 03/01/1996 - "Enhanced permeability following modification might allow the use of systematic delivery of these proteins for practical therapeutic treatment of various neurodegenerative disorders." 10/01/2006 - "In this review, we will describe how induction of autophagy is protective against toxic intracytosolic aggregate-prone proteins that cause a range of neurodegenerative diseases. " 05/01/2003 - "Immunization against extracellular neurotoxic proteins has shown promise in the treatment of several neurodegenerative disorders. " Order ALL the reference details at left...
5.	Carcinoma (Carcinomatosis) 07/01/2006 - "The fusion proteins were successfully incorporated into budded virions, which showed two- to fivefold-improved binding to human breast carcinoma (MDA-MB-435) and hepatocarcinoma (HepG2) cells. " 05/01/2004 - "Effective treatment of malignant carcinomas requires identification of proteins regulating epithelial cell proliferation. " 08/14/2005 - "CONCLUSION: Expression and localization of MUC1 proteins in primary liver carcinomas (PLCs) may act as prognostic markers, and MUC1 molecules might be helpful in differential diagnosis." 08/01/2009 - "We used immunohistochemistry to study the expression of these proteins in whole tissue sections of human breast carcinoma. " 01/01/2009 - "The aim of this study was to examine the expression of these proteins in gastric carcinoma. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Antibodies
2.	Antigens
3.	DNA (Deoxyribonucleic Acid)
4.	Vaccines
5.	Peptides
6.	Messenger RNA (mRNA)
7.	Biological Markers (Surrogate Marker)
8.	Immunoglobulin G (IgG)
9.	Cytokines
10.	Proteome

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Immunotherapy
3.	Therapeutics
4.	Heterologous Transplantation (Xenotransplantation)
5.	Oral Administration

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>